- I-Mab Biopharma (NASDAQ:IMAB) is scheduled to announce 1H earnings results on Wednesday, August 28th, before market open.
- The consensus EPS Estimate is -$0.55 (+47.6% Y/Y) and the consensus Revenue Estimate is $0.75M (-72.2% Y/Y).
- Over the last 1 year, IMAB has beaten EPS estimates 0% of the time and has beaten revenue estimates 25% of the time.
